| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $9.5M | -16.6% |
| Cost of Revenue | $9.7M | -15.8% |
| Gross Profit | -$198K | -65.3% |
| R&D Expense | $79K | -79.6% |
| SG&A Expense | $14.6M | +20.4% |
| Operating Income | -$14.8M | -20.8% |
| Pre-tax Income | -$34.3M | -95.0% |
| Net Income | -$34.3M | -95.0% |
| EPS (Basic) | -$63214.16 | — |
| EPS (Diluted) | -$63214.16 | — |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $148K | -48.7% |
| Accounts Receivable | $950K | -18.9% |
| Inventory | $2.8M | -39.5% |
| Current Assets | $5.6M | -10.8% |
| Total Assets | $31.8M | +218.0% |
| Current Liabilities | $26.0M | +70.1% |
| Total Liabilities | $27.4M | +55.6% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$7.2M | -2.9% |
| Capital Expenditures | $329K | — |
| Investing Cash Flow | -$329K | — |
| Financing Cash Flow | $10.0M | +61.1% |
| Free Cash Flow | -$7.6M | -7.6% |
| $4.4M |
| +157.4% |